Evidence map›Paper›PMID 42196588›Full record

ArticleInternational journal of molecular sciences2026

Insulin and Incretin Receptor Agonists Reciprocally Alter Their Blood-Brain Barrier Permeabilities.

Angeline Fry, Alexis Rose, Riley Weaver, Kim Hansen, James E Blevins, William A Banks, Elizabeth M Rhea

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Angeline FryGeriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA.
Alexis RoseGeriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA.ORCID 0009-0008-5266-9693
Riley WeaverGeriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA.ORCID 0000-0002-2555-8065
Kim HansenGeriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA.
James E BlevinsOffice of Research and Development, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA.
William A BanksGeriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA.ORCID 0000-0002-0496-3619
Elizabeth M RheaGeriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA 98108, USA.ORCID 0000-0001-8118-120X

Funding

BLRD VA I01 BX004102NIH HHS 1T35AG026757-24United States Department of Veterans Affairs I01BX004102
6 · The paper itself

Abstract

Incretin receptor agonists (IRAs) such as GLP-1-based therapies improve metabolic and cognitive outcomes and enhance brain insulin signaling. One way that IRAs could have these actions is by affecting the blood-brain barrier (BBB); however, IRA-BBB interactions are poorly studied. Here, we examined the ability of insulin and IRAs to affect each other's transport across the BBB in lean mice. We found that intracerebroventricular (ICV) administration of the insulin receptor antagonist S961 did not affect the blood-to-brain transport of the bioactive fragment of the IRA,

Indexed as

Blood-Brain BarrierIncretinsInsulinAnimalsBiological TransportBrainFemaleGlucagon-Like PeptidesHypoglycemic AgentsMaleMiceMice, Inbred C57BLPeptidesPermeabilityReceptor, InsulinSemaglutideGlucagon-Like PeptidesHypoglycemic AgentsIncretinsInsulinPeptidesReceptor, InsulinS961 peptideSemaglutideblood–brain barrierGLP-1 receptor agonistsincretin receptor agonistsinsulin

Identifiers

PMID42196588
PMCPMC13207238

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.